Clinical Trial Update: Feasibility of a Multi-omics Platform for Hematological Malignancies [NA]

View source ↗

Summary

This clinical trial update assesses the feasibility of a multi-omics platform for hematological malignancies and is currently recruiting. It is sponsored by Azi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Lymphoproliferative Neoplasms
• Multiple Myeloma
• Myelodysplastic Syndromes
• Myeloproliferative Neoplasms

Snippet

Sponsor: Azienda Ospedaliero-Universitaria di Parma | Conditions: Myeloma Multiple, Chronic Leukemia | NA | Status: RECRUITING